How should we treat newly diagnosed multiple myeloma patients?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 488-495

  Mateos, María Victoria ^a   San Miguel, Jesús F ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; IMMUNOLOGIC FACTOR; PROTEASOME INHIBITOR;

AGED; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; REVIEW;

AGED; ALKYLATING AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROTEASOME INHIBITORS;

EID: 84904519342     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.488     Document Type: Review

References (0)